Herceptin resistance database for understanding mechanism of resistance in breast cancer patients.
about
Context Sensitive Modeling of Cancer Drug SensitivityContext-specific functional module based drug efficacy prediction.Novel paradigm for immunotherapy of breast cancer by engaging prophylactic immunity against hepatitis BFunctionalized immunostimulating complexes with protein A via lipid vinyl sulfones to deliver cancer drugs to trastuzumab-resistant HER2-overexpressing breast cancer cellsIdentification of breast cancer cell subtypes sensitive to ATG4B inhibition.Trastuzumab in the Treatment of Breast Cancer.Managing Drug Resistance in Cancer: Role of Cancer Informatics.CD49f Can Act as a Biomarker for Local or Distant Recurrence in Breast Cancer.Design and In Vitro Evaluation of a Cytotoxic Conjugate Based on the Anti-HER2 Affibody Fused to the Fc Fragment of IgG1.Frequent detection of PIK3CA mutations in single circulating tumor cells of patients suffering from HER2-negative metastatic breast cancer.Blockade of CD112R and TIGIT signaling sensitizes human natural killer cell functions.Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges.KRDS: a web server for evaluating drug resistance mutations in kinases by molecular docking.Novel treatment strategies for patients with HER2-positive breast cancer who do not benefit from current targeted therapy drugsThe Cytotoxic and Antimigratory Activity of Brazilin-Doxorubicin on MCF-7/HER2 CellsStructural and functional characterization of MBS301, an afucosylated bispecific anti-HER2 antibody
P2860
Q28547285-4872B27F-DFE0-4273-A855-6886D93A862DQ36094642-0F72EBB1-9CAE-4594-9E58-063A82BAD6A2Q37187980-4F8EB203-2AB1-4017-863D-09EE346FFA2BQ37279627-5B7593ED-383E-4E5C-9450-FBC6E654B06EQ37687104-FB8139F8-5809-4EBE-9B20-0114456AD5ABQ38739914-22979F07-6659-4611-A70D-21EDD241F1BFQ38748135-1546716D-1A6C-46D3-B685-DF82FBAC5F40Q40953798-8F666D23-E33B-4C48-AEB3-F256180E2E6DQ41573532-D3584C14-4A8A-460F-ABD1-9027764FB8D5Q41763224-CCDAB9C5-D375-4D7A-B088-7495F6D01DDEQ48263702-B3059362-A7B1-472C-A2FA-815FF78C8672Q49887925-F163ACE0-1EA8-48F1-BCE7-904B01C83A66Q52597351-23D11957-F919-422F-B08D-266C0DE68815Q57106864-78AC9C93-6D09-419B-9958-6A81E3547EA8Q57136097-97288A33-799E-43A9-B14A-ED0B5D79F2C4Q58798280-D62BB5E1-3C4D-431F-AADF-71586F0E0F7D
P2860
Herceptin resistance database for understanding mechanism of resistance in breast cancer patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Herceptin resistance database ...... nce in breast cancer patients.
@en
Herceptin resistance database ...... nce in breast cancer patients.
@nl
type
label
Herceptin resistance database ...... nce in breast cancer patients.
@en
Herceptin resistance database ...... nce in breast cancer patients.
@nl
prefLabel
Herceptin resistance database ...... nce in breast cancer patients.
@en
Herceptin resistance database ...... nce in breast cancer patients.
@nl
P2093
P2860
P356
P1433
P1476
Herceptin resistance database ...... ance in breast cancer patients
@en
P2093
Grish C Varshney
Rahul Kumar
Sahil Ahmad
P2860
P2888
P356
10.1038/SREP04483
P407
P577
2014-03-27T00:00:00Z